---
schema_version: "secwatch.filing_event.v1"
accession: "0001711279-23-000069"
form_type: "8-K"
ticker: "KRYS"
cik: "0001711279"
company_name: "Krystal Biotech, Inc."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T04:31:25.312215+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Krystal Biotech Chief Commercial Officer Andrew Orth resigns

## Summary
- Andrew Orth resigned as Chief Commercial Officer, effective August 2, 2023.
- No successor has been announced; reason for departure not disclosed.
- The resignation is reported under Item 5.02 of Form 8-K.

## SEC filing metadata
- accession: 0001711279-23-000069
- form_type: 8-K
- ticker: KRYS
- cik: 0001711279
- company_name: Krystal Biotech, Inc.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711279/000171127923000069/0001711279-23-000069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711279/000171127923000069/krys-20230802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001711279-23-000069
- JSON: https://secwatch.observer/filing/0001711279-23-000069.json
- Plain text: https://secwatch.observer/filing/0001711279-23-000069.txt

## Key facts
- Executive change
  Andrew Orth resigned as Chief Commercial Officer at Krystal Biotech, Inc..
  - Action: resigned
  - Role: Chief Commercial Officer
  source text: Andrew Orth, the Company’s Chief Commercial Officer, notified the Company that he was resigning from his position and his last day with the Company was August 2, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1711279/000171127923000069/0001711279-23-000069-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.